
    
      All study sites will be in China. Subjects successfully implanted with the Micra system in
      all sites will be followed at implant/pre-discharge, 1-month, 3-months, and 6-months, and at
      6-month intervals thereafter (if applicable) through study closure. The overall follow-up
      period of the study will end when the last enrolled patient has 6 months of follow-up.
    
  